发明名称 |
An oral formulation for ileum administering comprising an inhibitor compound of the ileal bile acid transport. |
摘要 |
An oral pharmaceutical formulation comprising an inhibitor compound of the ileal bile acid transport (IBAT inhibitor compound) and a therapeutically acceptable carrier characterised in that the formulation is designed to deliver the IBAT inhibitor compound in the ileum. The IBAT inhibitor compound can also be administered in combination with a bile acid binder to alleviate possible side effects of therapy with IBAT inhibitor compound, such as for instance diarrhoea. The bile acid binder may be formulated for colon release. |
申请公布号 |
ZA200108539(B) |
申请公布日期 |
2003.01.17 |
申请号 |
ZA20010008539 |
申请日期 |
2001.10.17 |
申请人 |
ASTRAZENECA AB. |
发明人 |
BERTIL ABRAHAMSSON;ANNA-LENA UNGELL;ANN-MARGRET LINDQVIST |
分类号 |
A61K47/30;A61K9/20;A61K9/50;A61K31/00;A61K31/554;A61K45/00;A61K45/06;A61P3/06 |
主分类号 |
A61K47/30 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|